Cannabidiol pain cream products in a pharmacy in Remington, Virginia.KRISTOFFER TRIPPLAAR/SIPA VIA AP

“The $300 billion CBD industry is giving Washington a major headache. The cannabis extract is used as a home remedy for everything from pain to anxiety, and celebrities are even considering adding the extract to wine. But this lack of a clear line between therapeutic and food additive means that the FDA is unsure whether to regulate the product as a therapeutic or to treat CBD the way it treats vitamins and other nutritional supplements. “’The FDA needs to take a leadership position as quickly as possible to make sure that the wild west of CBD doesn’t harm the public health,’ Peter Pitts, president of the Center for Medicine in the Public Interest and a former FDA official.”

“WASHINGTON — Online reviews proclaim CBD a “life changer,” “the best thing ever,” and “truly incredible.” It’s a $390 million industry, expected to grow to at least $1.3 billion by 2022. Montel Williams has his own designer line of CBD products; so do Tommy Chong and Mike Tyson.

Despite the rave reviews, CBD is giving Washington a major headache. The Food and Drug Administration has different rules for regulating medicines and dietary supplements like vitamins — and it isn’t perfectly clear yet which category CBD, or cannabidiol, an extract of cannabis used as a home remedy for everything from anxiety to back pain, falls into. Congress, too, has struggled. Lawmakers passed a bill last year that officially legalized hemp, the plant from which CBD is extracted, but left the FDA will little guidance on how to regulate CBD.”

Click here to continue reading this article at STATNews.